Disclosed are the ERK inhibitors of formula 1.0:and the pharmaceutically acceptable salts, and solvates thereof. Q is a tetrahydopyridinyl ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.本發明所揭示者為式1.0之ERK抑制劑:及其藥學上可接受之鹽與溶劑合物。Q為四氫吡啶基環。所有其他取代基均如本文定義。亦揭示者為使用式1.0化合物治療癌症之方法。